IL98785A - Pyrazolidinones and derivatives of pyrazoline-3 competitors of KCC and gastrin and pharmaceutical preparations containing them - Google Patents

Pyrazolidinones and derivatives of pyrazoline-3 competitors of KCC and gastrin and pharmaceutical preparations containing them

Info

Publication number
IL98785A
IL98785A IL9878591A IL9878591A IL98785A IL 98785 A IL98785 A IL 98785A IL 9878591 A IL9878591 A IL 9878591A IL 9878591 A IL9878591 A IL 9878591A IL 98785 A IL98785 A IL 98785A
Authority
IL
Israel
Prior art keywords
phenyl
alkyl
hydrogen
group
formula
Prior art date
Application number
IL9878591A
Other languages
English (en)
Hebrew (he)
Other versions
IL98785A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL98785A0 publication Critical patent/IL98785A0/xx
Publication of IL98785A publication Critical patent/IL98785A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9878591A 1990-07-17 1991-07-10 Pyrazolidinones and derivatives of pyrazoline-3 competitors of KCC and gastrin and pharmaceutical preparations containing them IL98785A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55348990A 1990-07-17 1990-07-17

Publications (2)

Publication Number Publication Date
IL98785A0 IL98785A0 (en) 1992-07-15
IL98785A true IL98785A (en) 1995-11-27

Family

ID=24209587

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9878591A IL98785A (en) 1990-07-17 1991-07-10 Pyrazolidinones and derivatives of pyrazoline-3 competitors of KCC and gastrin and pharmaceutical preparations containing them

Country Status (19)

Country Link
EP (1) EP0467614A1 (pt)
JP (1) JPH04230367A (pt)
KR (1) KR960005950B1 (pt)
CN (1) CN1032000C (pt)
AU (2) AU644190B2 (pt)
BR (1) BR9103042A (pt)
CA (1) CA2046672A1 (pt)
CS (1) CS219391A3 (pt)
FI (1) FI913431A (pt)
HU (1) HUT58296A (pt)
IE (1) IE912489A1 (pt)
IL (1) IL98785A (pt)
MX (1) MX9100164A (pt)
NO (1) NO912772L (pt)
NZ (1) NZ238912A (pt)
PT (1) PT98323A (pt)
RU (1) RU2076100C1 (pt)
YU (1) YU124391A (pt)
ZA (1) ZA915372B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
US5153191A (en) * 1991-08-20 1992-10-06 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5399708A (en) * 1993-11-12 1995-03-21 Eli Lilly And Company Pyrazolidin-3-one derivatives
GB0011095D0 (en) 2000-05-08 2000-06-28 Black James Foundation astrin and cholecystokinin receptor ligands (III)
PE20020856A1 (es) * 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
UA79804C2 (en) 2002-07-03 2007-07-25 Janssen Pharmaceutica Nv Cck-1 receptor modulators
GB0312368D0 (en) * 2003-05-30 2003-07-02 Univ Aston Novel ureido- and amido-pyrazolone derivatives
US8410135B2 (en) * 2007-06-15 2013-04-02 Solvay Pharmaceuticals B.V. 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
EP3883925A4 (en) * 2018-11-20 2021-12-29 Sironax Ltd Cyclic ureas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE530886A (pt) * 1953-08-03
FR82186E (fr) * 1959-04-10 1964-01-04 Kodak Pathe Nouveau produit photographique et procédé pour le traitement de ce produit
FR2529786A1 (fr) * 1982-07-12 1984-01-13 Nativelle Sa Ets Compositions pharmaceutiques a base de derives de la pyrazolone-5, nouveaux produits et procede de preparation
DE3407506A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoline, verfahren zu ihrer herstellung und deren verwendung
EP0166355A2 (en) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituted aminophenyl compounds and acylaminophenyl compounds and pharmaceutical compositions containing them
US5089622A (en) * 1988-12-12 1992-02-18 Mitsui Toatsu Chemicals Incorporated (-)-2-pyrazoline compounds and therapeutic agent for cerebrovascular disorders containing the same as effective ingredient
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents

Also Published As

Publication number Publication date
PT98323A (pt) 1992-06-30
HU912376D0 (en) 1991-12-30
AU8040991A (en) 1992-01-23
RU2076100C1 (ru) 1997-03-27
ZA915372B (en) 1993-03-31
YU124391A (sh) 1994-01-20
FI913431A (fi) 1992-01-18
KR960005950B1 (ko) 1996-05-06
NO912772L (no) 1992-01-20
IL98785A0 (en) 1992-07-15
NO912772D0 (no) 1991-07-15
CN1058209A (zh) 1992-01-29
BR9103042A (pt) 1992-04-28
AU5529394A (en) 1994-04-28
CS219391A3 (en) 1992-02-19
JPH04230367A (ja) 1992-08-19
CA2046672A1 (en) 1992-01-18
KR920002548A (ko) 1992-02-28
CN1032000C (zh) 1996-06-12
FI913431A0 (fi) 1991-07-16
AU644190B2 (en) 1993-12-02
MX9100164A (es) 1992-02-28
NZ238912A (en) 1992-12-23
EP0467614A1 (en) 1992-01-22
HUT58296A (en) 1992-02-28
IE912489A1 (en) 1992-01-29

Similar Documents

Publication Publication Date Title
US5681833A (en) Benzodiazepine derivatives
US5618812A (en) Benzodiazepine derivatives
US5360802A (en) Benzodiazepine derivatives, compositions containing them and their use in therapy
US5451582A (en) Benzodiazepine derivatives, compositions containing them and their use in therapy
US5410049A (en) Benzodiazepine derivatives, compositions containing them and their use in therapy
US5302591A (en) Benzodiazepine derivatives
US6143762A (en) Tetrahydroisoquinoline derivatives and their pharmaceutical use
US5478933A (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
EP0475755B1 (en) 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof
AU667690B2 (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
KR20130094311A (ko) P2x4 수용체 길항제
IL98785A (en) Pyrazolidinones and derivatives of pyrazoline-3 competitors of KCC and gastrin and pharmaceutical preparations containing them
US5602125A (en) Thienodiazepine derivatives as cholecystokinin and gastrin antagonists
EP0595980A1 (en) Benzodiazepine derivatives, compositions containing them and their use in therapy
LV12314B (en) HOLECISTOKININ ANTAGONISTS
US5399565A (en) Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
US5696110A (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
US5620972A (en) Substituted benzene derivatives
US5643926A (en) Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
JPH08198875A (ja) インドリジノン誘導体
GB2266528A (en) Benzodiazepine derivatives
KR20050016991A (ko) Mchir 길항제

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void